4 options
Boron and gadolinium neutron capture therapy for cancer treatment / Narayan S. Hosmane ... [et al.].
- Format:
- Book
- Author/Creator:
- Hosmane, Narayan S.
- Language:
- English
- Subjects (All):
- Cancer--Treatment.
- Cancer.
- Boron-neutron capture therapy.
- Boron.
- Gadolinium.
- Physical Description:
- 1 online resource (271 p.)
- Edition:
- 1st ed.
- Place of Publication:
- Singapore : World Scientific Pub. Co., 2012.
- Summary:
- The book focuses on two concurrent experimental therapies in cancer treatment known as boron neutron capture therapy (BNCT) and gadolinium neutron capture therapy (GdNCT) using a variety of boron- and gadolinium-based compounds. Some of the gadolinium compounds serve the dual purpose as being MRI contrast agents and GdNCT agents. The book describes why BNCT & GdNCT were not at the forefront of the clinical trials during the past seven to eight decades since the discovery of neutrons by John Chadwick in 1932 and how the latest development in the synthesis of target boron- and gadolinium-based drugs has turned the area into the hottest one worthy of further investigation with the new clinical trials in the USA and elsewhere.
- Contents:
- What is cancer?
- Principles of neutron capture therapy
- Major neutron capture therapy (NCT) drug prototypes
- Neutron sources for NCT
- NCT dosimetry and treatment planning
- Selected in vitro and in vivo studies
- Clinical trials
- Future perspectives for boron and gadolinium neutron capture therapies in cancer treatment
- Clinical state of BNCT by US Department of Energy (DOE) as at 1997.
- Notes:
- Description based upon print version of record.
- Includes bibliographical references and index.
- ISBN:
- 9786613646347
- 9781280669415
- 1280669411
- 9789814338684
- 9814338680
- OCLC:
- 794328398
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.